NCT03293914 is a NA clinical trial of Lifestyle Redesign in Diabetes Mellitus, sponsored by University of Southern California.

Who is sponsoring NCT03293914?

NCT03293914 is sponsored by University of Southern California.

What drugs are being tested in NCT03293914?

Interventions in NCT03293914: Lifestyle Redesign.

What condition does NCT03293914 study?

NCT03293914 studies Diabetes Mellitus.

Is NCT03293914 still recruiting?

NCT03293914 is currently completed. Last updated 24 March 2020.

Last reviewed 2020-03-24 · How we verify

NCT03293914

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Addressing Uncontrolled Diabetes in Primary Care: A Lifestyle Redesign Approach

Completed NA Last updated 24 March 2020

What this trial tests

NA trial testing Lifestyle Redesign in Diabetes Mellitus in 143 participants. Completed in 30 November 2019.

Timeline

18 September 2017

Primary endpoint
31 May 2019

30 November 2019

Quick facts

Lead sponsor	University of Southern California
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	143
Start date	18 September 2017
Primary completion	31 May 2019
Estimated completion	30 November 2019
Sites	1 location across United States

Drugs / interventions tested

Lifestyle Redesign

Conditions studied

Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

University of Southern California

Who can join

Adults 18 to 75, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is examining the feasibility of implementing an occupational therapy intervention addressing diabetes management in a primary care clinic within the Los Angeles County Department of Health Services (LAC-DHS), as well as the impact of this intervention approach on clinical outcomes, efficiency and patient-centeredness of care. This implementation science study is evaluating two emerging trends in healthcare delivery: (1) the integration of nontraditional providers into primary care medical home (PCMH) settings to facilitate the delivery of high-quality, comprehensive primary care while reducing the burden on physicians; and (2) the potential value of using occupational therapists to address chronic disease management in this setting

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Addressing Diabetes in Primary Care: Hybrid Effectiveness-Implementation Study of Lifestyle Redesign<sup>®</sup> Occupational Therapy.
Pyatak E, King M, Vigen CLP, Salazar E, et al · · 2019 · cited 16× · PMID 31484021 · DOI 10.5014/ajot.2019.037317
Primary Care Lifestyle Redesign<sup>®</sup> Clinical Trial: Diabetes Outcomes, Healthcare Utilization, and Costs.
A Tapia V, Niemiec SS, Leite JD, Diaz J, et al · · 2026 · PMID 41739526 · DOI 10.1177/00084174261421403

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting

Other University of Southern California trials

Trials by the same sponsor.

NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03293914 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southern California
Last refreshed: 24 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03293914.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing